Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Introducing a new component of the metabolic syndrome: low cholesterol absorption.

Simonen P, Gylling H, Howard AN, Miettinen TA.

Am J Clin Nutr. 2000 Jul;72(1):82-8.

2.

Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics.

Simonen PP, Gylling H, Miettinen TA.

Obes Res. 2002 May;10(5):328-35.

3.

Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men.

Stranberg TE, Salomaa V, Vanhanen H, Miettinen TA.

Diabetes. 1996 Jun;45(6):755-61.

PMID:
8635649
4.

Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes.

Simonen P, Gylling H, Miettinen TA.

Clin Chim Acta. 2002 Feb;316(1-2):55-61.

PMID:
11750274
5.

Low synthesis and high absorption of cholesterol characterize type 1 diabetes.

Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V.

Diabetes Care. 2004 Jan;27(1):53-8.

PMID:
14693966
6.
8.

Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.

Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP.

Ann Intern Med. 2005 Mar 15;142(6):403-11.

PMID:
15767618
9.

Influence of 4 weeks' intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes.

Halle M, Berg A, Garwers U, Baumstark MW, Knisel W, Grathwohl D, König D, Keul J.

Metabolism. 1999 May;48(5):641-4.

PMID:
10337867
10.
11.

Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program.

Kiortsis DN, Tzotzas T, Giral P, Bruckert E, Beucler I, Valsamides S, Turpin G.

Nutr Metab Cardiovasc Dis. 2001 Jun;11(3):153-7.

PMID:
11590990
12.
13.
14.

Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.

Miyashita Y, Koide N, Ohtsuka M, Ozaki H, Itoh Y, Oyama T, Uetake T, Ariga K, Shirai K.

Diabetes Res Clin Pract. 2004 Sep;65(3):235-41.

PMID:
15331203
15.
16.

Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.

Palomba S, Russo T, Orio F Jr, Sammartino A, Sbano FM, Nappi C, Colao A, Mastrantonio P, Lombardi G, Zullo F.

Hum Reprod. 2004 Feb;19(2):415-21.

PMID:
14747190
17.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
18.
19.

Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome.

Hallikainen M, Toppinen L, Mykkänen H, Agren JJ, Laaksonen DE, Miettinen TA, Niskanen L, Poutanen KS, Gylling H.

Am J Clin Nutr. 2006 Dec;84(6):1385-92.

20.

Supplemental Content

Support Center